DeepGraphMut:一种基于图形的深度学习方法,用于使用体质突变档案进行癌症预后
Aswin Jose1, Akansha Srivastava1, Ariba Ansari1
1Centre for Computational Natural Sciences and Bioinformatics, IIIT Hyderabad, Prof. C R Rao Road, Gachibowli, Hyderabad 500032, India.
Briefings in bioinformatics
|August 15, 2025
概括
DeepGraphMut (DGM) 使用突变数据和蛋白质网络识别癌症亚型. 这种基于图表的深度学习工具有助于癌症预后和个性化医疗,即使数据有限.
科学领域:
- 计算生物学 计算生物学
- 基因组学就是基因组学.
- 网络生物学 网络生物学
背景情况:
- 癌症的复杂性和异质性挑战亚型识别,尽管基因组的进步.
- 准确的癌症亚型确定对于有效的治疗和预后至关重要.
研究的目的:
- 引入DeepGraphMut (DGM),一种基于图形的新型深度学习管道,用于癌症亚型识别.
- 为了利用体质突变数据和蛋白质-蛋白质相互作用 (PPI) 网络为患者特定的编码.
- 评估DGM在无监督和监督癌症分析中的有效性.
主要方法:
- 开发了DeepGraphMut (DGM),一个基于图形的深度学习管道,将体质突变数据与PPI网络集成在一起.
- 采用了带有图表注意力的图形自编码器和节点级注意力解码器来生成特定于患者的编码.
- 在来自癌症基因组图谱 (TCGA) 的16种癌症类型的7352个样本上验证了DGM.
主要成果:
- 无监督集群确定了不同的癌症亚型,在16种癌症类型中的11种癌症中存在显著的生存差异.
- 使用考克斯回归的监督分析表明,DGM的生存预测性能强大 (C指数~0.7).
- 在无监督和监督任务中,DGM的表现优于其轻量级版本和其他基于网络的方法.
结论:
- DeepGraphMut (DGM) 为癌症亚型的发现和预后提供了一种有希望的方法,特别是在资源有限的环境中.
- 该管道有效地利用体质突变数据和网络生物学来实现个性化医学应用.
- DGM为推进癌症研究和临床决策提供了有价值的工具.
相关概念视频
Cancer Survival Analysis
455
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
455
Cancers Originate from Somatic Mutations in a Single Cell
12.7K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.7K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K


